Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback